306 studies found for:    ferritin
Show Display Options
Rank Status Study
1 Not yet recruiting Efficacy and Safety of Efficacy and Safety of Continued Iron Chelation Therapy In Poly-transfused Thalassemia Patients With Low Serum Ferritin (< 500 ng/ml)
Conditions: Beta-thalassemia;   Serum Ferritin;   Iron Chelation Therapy
Intervention: Drug: desferal, ferriprox, blood transfusion
2 Completed Effect of Timing of Umbilical Cord Clamping on Haematological and Clinical Outcomes of Infants
Conditions: Anemia;   Ferritin;   Complications;   Hemorrhage;   Jaundice
Interventions: Procedure: Early Cord Clamping;   Procedure: Delayed Cord Clamping
3 Completed DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Conditions: Anemia, Iron-Deficiency;   Kidney Failure, Chronic;   Hemodialysis
Intervention: Drug: Sodium ferric gluconate,
4 Recruiting HEPFER-Evaluation of a New Phenotypic Biological Marker in Genetic Type 1 Hemochromatosis
Condition: Hereditary Hemochromatosis C282Y Homozygous
Intervention:
5 Completed
Has Results
Iron Indices and Intravenous Ferumoxytol: Time to Steady State
Condition: Iron Deficiency Anemia
Intervention: Drug: ferumoxytol
6 Suspended Interest of Biofer ® Compound Used in Blédilait Follow on Milk in Infant With Latent Iron Deficiency
Condition: Latent Iron Deficiency
Interventions: Drug: Bledilait Biofer®;   Drug: Milk supplemented with ferrous sulphate;   Drug: Blédilait Biofer®
7 Completed
Has Results
Clinical Evaluation of Iron Treatment Efficiency Among Non-anemic But Iron-deficient Female Blood Donors
Conditions: Fatigue;   Iron Deficiency
Interventions: Drug: Ferrous sulphate;   Drug: Placebo
8 Unknown  Study Of Efficacy,Safety of Combined Deferasirox and Deferiprone Versus Combined Deferiprone and Desferal In Conditions of Iron Overload
Conditions: Beta-thalassemia Major;   Sickle Cell Disease;   Iron Hemosiderosis
Interventions: Drug: DFP (ferriprox) and deferasirox (ICL 670);   Drug: DFP, DFO
9 Completed Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis
Conditions: Chronic Anemia;   Transfusional Hemosiderosis
Intervention: Drug: Deferasirox (ICL670)
10 Completed Timing of Iron Supplementation in Very Low Birth Weight Infants
Condition: Nutritional Status
Intervention: Drug: Elemental iron
11 Completed Does the Reduction of Total Body Iron Storage (TBIS) Alter Mortality in a Population of Patients With Advanced PVD?
Conditions: Atherosclerosis;   Intermittent Claudication;   Peripheral Vascular Diseases
Intervention: Procedure: Ferritin reduction to 25 ng/ml by phlebotomy
12 Recruiting Effect Of Intravenous Iron Versus Placebo On Muscle Oxidative Capacity And Physical Performance In Non Anemic Premenopausal Women With Low Ferritin Levels
Condition: Non Anemic Patients With Iron Deficiency (Low Ferritin Value)
Intervention: Drug: Double blind, randomized, placebo controlled inter
13 Completed The Association of Ferrtin and Homocysteine Etc. With RI and MS in Polycystic Ovary Syndrome (PCOS)
Condition: Polycystic Ovary Syndrome
Intervention:
14 Completed
Has Results
Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration)
Conditions: Beta-thalassemia Major;   Hemosiderosis;   Iron Overload;   Rare Anemia
Intervention: Drug: Deferasirox
15 Completed Efficacy and Safety of Oral Deferasirox (20 mg/kg/d) in Pts 3 to 6 Months After Allogeneic Hematopoietic Cell Transplantation Who Present With Iron Overload
Condition: Iron Overload
Intervention: Drug: Deferasirox
16 Completed
Has Results
Nutritional Education and the Prevention of Iron Depletion in Children 9 Months to 2 Years
Condition: Iron Deficiency
Interventions: Other: Healthy milk intake;   Other: Standard nutrition counselling
17 Completed Iron Overload in Patients Undergoing Donor Stem Cell Transplant
Conditions: Cancer;   Hematopoietic Stem Cell Transplantation;   Allogeneic Hematopoietic Cell Transplantation
Interventions: Procedure: magnetic resonance imaging;   Procedure: Serum ferritin
18 Active, not recruiting Erythrocytapheresis Versus Phlebotomy as Maintenance Therapy in Hereditary Hemochromatosis (HH) Patients
Condition: Hereditary Hemochromatosis
Intervention: Other: Phlebotomy and erythrocytapheresis
19 Not yet recruiting A Randomized Pilot Study of Ferric Carboxymaltose as Compared to Iron Sucrose for the Treatment of Functional Iron Deficiency Associated With Surgical Critical Illness
Conditions: ICU Anemia;   Functional Iron Deficiency
Interventions: Drug: Ferric carboxymaltose;   Drug: Iron sucrose
20 Recruiting Treatment of Iron Overload With Deferasirox (Exjade) in Hereditary Hemochromatosis and Myelodysplastic Syndrome
Conditions: Hemochromatosis;   Myelodysplastic Syndromes
Interventions: Drug: Deferasirox;   Other: Venesection

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years